Held by 103 funds across 15 fund houses in our coverage.
Coverage: 22 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Dr. Reddy's Laboratories is held by 103 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹6,843 Cr. Among all holding funds, the manager with the highest conviction is ICICI Prudential Pharma Healthcare and Diagnostics Fund (ICICI Pru MF), which allocates a significant 8.45% of its entire portfolio to Dr. Reddy's Laboratories.
In terms of category distribution, ETF funds hold the largest exposure by market value, representing 29 positions. Across different fund houses, ICICI Pru MF manages the largest aggregate stake, holding a combined value of ₹4,264 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
Portfolios as on: ICICI Pru MF Jul 2026 · Aditya Birla SL MF Apr 2026 · DSP MF Jul 2026 · Motilal Oswal MF Jul 2026 · Groww MF Oct 2025 · UTI MF Jul 2026 · SBI MF Jul 2026 · Kotak MF Jul 2026 · LIC MF Jul 2026 · Franklin Templeton MF Jul 2026 · Mirae Asset MF Jul 2026 · HDFC MF Jul 2026 · ITI MF Jul 2026 · Axis MF Jul 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).